Immune Pharmaceuticals Announces 1-for-20 Reverse Stock Split

NEW YORK, April 12, 2017 /PRNewswire/ — Immune Pharmaceuticals Inc. (Nasdaq: IMNP) (“Immune” or the “Company”), today announced a reverse stock split of its shares of common stock at a ratio of 1-for-20. Beginning with the opening of trading on April 13, 2017, the Company’s common stock will continue to trade The Nasdaq Capital Market (“Nasdaq”)…